Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_assertion description "[The authors concluded that FGFR 4 must be an important factor which predicts short survival Grade III astrocytoma patients, who require strict adjuvant therapy in accordance with glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_assertion evidence source_evidence_literature NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_assertion SIO_000772 11958417 NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_assertion wasDerivedFrom befree-20150227 NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_assertion wasGeneratedBy ECO_0000203 NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.
- befree-20150227 importedOn "2015-02-27" NP402024.RAwOE2PzL9sUqhv7QpmIKfml4snAhgZbO3YK9mDBPqV3g130_provenance.